Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Watson to Gain Ability to “See” with Planned $1B Acquisition of Merge Healthcare

Deal Brings Watson Technology Together with Leader in Medical Images

Armonk, NY and CHICAGO — [August 6, 2015]:  IBM (NYSE: IBM) today announced that Watson will gain the ability to “see” by bringing together Watson’s advanced image analytics and cognitive capabilities with data and images obtained from Merge Healthcare Incorporated’s (NASDAQ: MRGE) medical imaging management platform.  IBM plans to acquire Merge, a leading provider of medical image handling and processing, interoperability and clinical systems designed to advance healthcare quality and efficiency, in an effort to unlock the value of medical images to help physicians make better patient care decisions.

Merge’s technology platforms are used at more than 7,500 U.S. healthcare sites, as well as most of the world’s leading clinical research institutes and pharmaceutical firms to manage a growing body of medical images.  The vision is that these organizations could use the Watson Health Cloud to surface new insights from a consolidated, patient-centric view of current and historical images, electronic health records, data from wearable devices and other related medical data, in a HIPAA-enabled environment.

Under terms of the transaction, Merge shareholders would receive $7.13 per share in cash, for a total transaction value of $1 billion.  The closing of the transaction is subject to regulatory review, Merge shareholder approval, and other customary closing conditions, and is anticipated to occur later this year.  It is IBM’s third major health-related acquisition – and the largest – since launching its Watson Health unit in April, following Phytel (population health) and Explorys (cloud based healthcare intelligence).

“As a proven leader in delivering healthcare solutions for over 20 years, Merge is a tremendous addition to the Watson Health platform.  Healthcare will be one of IBM’s biggest growth areas over the next 10 years, which is why  we are making a major investment to drive industry transformation and to facilitate a higher quality of care,” said John Kelly, senior vice president, IBM Research and Solutions Portfolio. “Watson’s powerful cognitive and analytic capabilities, coupled with those from Merge and our other major strategic acquisitions, position IBM to partner with healthcare providers, research institutions, biomedical companies, insurers and other organizations committed to changing the very nature of health and healthcare in the 21st century. Giving Watson ‘eyes’ on medical images unlocks entirely new possibilities for the industry.”

Teaching Watson to “See” Medical Images
The planned acquisition bolsters IBM’s strategy to add rich image analytics with deep learning to the Watson Health platform – in effect, advancing Watson beyond natural language and giving it the ability to “see.”  Medical images are by far the largest and fastest-growing data source in the healthcare industry and perhaps the world – IBM researchers estimate that they account for at least 90% of all medical data today – but they also present challenges that need to be addressed:

  • The volume of medical images can be overwhelming to even the most sophisticated specialists – radiologists in some hospital emergency rooms are presented with as many as 100,000 images a day1.
  • Tools to help clinicians extract insights from medical images remain very limited, requiring most analysis to be done manually.
  • At a time when the most powerful insights come at the intersection of diverse data sets (medical records, lab tests, genomics, etc.), medical images remain largely disconnected from mainstream health information.

IBM plans to leverage the Watson Health Cloud to analyze and cross-reference medical images against a deep trove of lab results, electronic health records, genomic tests, clinical studies and other health-related data sources, already representing 315 billion data points and 90 million unique records.  Merge’s clients could compare new medical images with a patient’s image history as well as populations of similar patients to detect changes and anomalies. Insights generated by Watson could then help healthcare providers in fields including radiology, cardiology, orthopedics and ophthalmology to pursue more personalized approaches to diagnosis, treatment and monitoring of patients.

Cutting-edge image analytics projects underway in IBM Research’s global labs suggest additional areas where progress can be made.  They include teaching Watson to filter clinical and diagnostic imaging information to help clinicians identify anomalies and form recommendations, which could help reduce physician viewing loads and increase physician effectiveness.

“As Watson evolves, we are tackling more complex and meaningful problems by constantly evaluating bigger and more challenging data sets,” Kelly said. “Medical images are some of the most complicated data sets imaginable, and there is perhaps no more important area in which researchers can apply machine learning and cognitive computing.  That’s the real promise of cognitive computing and its artificial intelligence components – helping to make us healthier and to improve the quality of our lives.”

Watson Health and Merge Capabilities Will Benefit Researchers, Clinicians and Individuals
IBM’s Watson Health unit plans to bring together Merge’s product and solution offerings with existing expertise in cognitive computing, population health, and cloud-based healthcare intelligence offerings to:

  • Offer researchers insights to aid clinical trial design, monitoring and evaluation;
  • Help clinicians to efficiently identify options for the diagnosis, treatment  and monitoring a broad array of health conditions such as cancer, stroke and heart disease;
  • Enable providers and payers to integrate and optimize patient engagement in alignment with meaningful use and value-based care guidelines; and
  • Support researchers and healthcare professionals as they advance the emerging discipline of population health, which aims to optimize an individual’s care by identifying trends in large numbers of people with similar health status.

“Merge is widely recognized for delivering market leading imaging workflow and electronic data capture solutions,” said Justin Dearborn, chief executive officer, Merge. “Today’s announcement is an exciting step forward for our employees and clients. Becoming a part of IBM will allow us to expand our global scale and deliver added value and insight to our clients through Watson’s advanced analytic and cognitive computing capabilities.”

“Combining Merge’s leading medical imaging solutions with the world-class machine learning and analytics capabilities of IBM’s Watson Health is the future of healthcare technology,” said Michael W. Ferro, Jr., Merge’s chairman. “Merge’s leading technology and proven expertise represent a unique combination of assets that will deliver unparalleled value to Watson Health clients. Together, we will unlock unprecedented new opportunities to improve patient diagnostics and deliver enhanced care.”

About Merge
Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge’s enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide. For more information, visit merge.com and follow us @MergeHealthcare.

IBM Watson: Pioneering a New Era of Computing
Watson is the first commercially available cognitive computing capability representing a new era in computing. The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers. Watson continuously learns, gaining in value and knowledge over time, from previous interactions.

In January 2014, IBM launched the IBM Watson unit, a business dedicated to developing and commercializing cloud-delivered cognitive computing technologies. The move signified a strategic shift by IBM to deliver a new class of software, services and apps that improves by learning, and discovers insights from massive amounts of Big Data.  As part of the unit, the company has increased the number and diversity of cognitive computing services delivered to its partners, adding new beta Watson services in February 2015, and scalable deep learning APIs with the acquisition of AlchemyAPI in March 2015.

In April 2015, the company continued to build on its strengths in cognitive computing, analytics, security and cloud with the launch of IBM Watson Health and the Watson Health Cloud platform.  The new unit will help improve the ability of doctors, researchers and insurers to innovate by surfacing new insights from the massive amount of personal health data being created daily.  The Watson Health Cloud allows this information to be anonymized, shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data.

About IBM
For more information on IBM Watson, visit: ibm.com/watson.  For more information on IBM Watson Health, visit: ibm.com/watsonhealth

Check out the IBM Watson press kit at: http://www-03.ibm.com/press/us/en/presskit/27297.wss

Join the conversation at #ibmwatson and #watsonhealth. Follow Watson on Facebook and see Watson on YouTube and Flickr.

Learn more about this story at: http://asmarterplanet.com/blog/2015/08/seeing-believing-bringing-cognitive-image-analytics-healthcare.html

– See more at: http://www.merge.com/News/Article.aspx?ItemID=660#sthash.YZ8EBkQT.dpuf

August 6, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Premier, Inc. to acquire CECity, Inc., expanding its performance improvement capabilities across the healthcare continuum

  • Extends seamless performance analytics and improvement platform across the entire ambulatory and acute care spectrum, creating opportunities for growth and expansion.
  • Simplifies and consolidates value-based payment reporting, automating the submission of physician practice and hospital data to private and public payers, and clinical data registries to scale improvement.

CHARLOTTE, N.C. (AUG. 4, 2015) — Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, reached an agreement to acquire CECity, Inc., for $400 million. CECity is a privately-held, SaaS-based healthcare solutions provider, specializing in performance management and improvement, pay-for-value reporting and professional education.

Both organizations are industry-leading influencers that complement one another as they help providers holistically deliver higher-quality, more cost-effective care. Premier unites an alliance of 3,400 hospitals and health systems, as well as 110,000 non-acute sites of care. CECity serves more than 1.2 million individual healthcare professionals; more than 5,000 individual practices; and more than 100 professional societies, quality improvement organizations and certifying boards.

“This transaction is exciting and timely for many reasons,” said Susan DeVore, president and chief executive officer of Premier. “We are enhancing our capability to provide turn-key performance improvement and measurement reporting solutions in a rapidly expanding market. These capabilities are critical given the ongoing movement toward population health, as well as emerging Medicare requirements for all physicians to start reporting on a range of new performance measurements,” she said.

Michael J. Alkire, chief operating officer of Premier, said, “The combination will support unique, end-to-end solutions that span the continuum of care, supporting providers as they move toward advanced payment models.  Our many capabilities will include furthering physicians’ abilities to meet and exceed all value-based payment and meaningful use requirements; enabling medical practices to send clinical patient data in real time to designated registries; and deepening our relationships with healthcare professionals across North America through private and public portals.”

Integrating CECity’s capabilities, Premier will provide one consolidated source for both ambulatory and acute care performance management that supports and aligns providers with value-based care. Premier’s payer and vendor-agnostic platform will be enhanced with expanded data collection, measurement and monitoring, expanding the ability to offer quality cycle management, regulatory reporting and performance improvement services. Premier will also have the ability to automate the flow of information directly from physician practices to qualified clinical data registries, in partnership with national professional societies, accelerating improvement and the delivery of high-quality, coordinated care. In addition, combining CECity’s integrated and extensible learning management platform with the collaborative learning and research services developed by Premier and its members will further advance and expand evidence-based quality improvement solutions.

“Our two companies share the same goal of transforming healthcare,” said Lloyd Myers, RPh, CECity president and chief executive officer. “Together we will offer seamless, cloud-based solutions across the continuum of care that make information exchange and pay-for-value reporting both secure and simple for hospitals, providers and payers. We believe this is a ‘game changer’ that can fulfill the promise of continuous learning health systems to improve quality and safety for hospitals, healthcare professionals and their patients, at scale.”

CECity and its 134 employees/contractors will continue to operate out of its headquarters in Pittsburgh for the foreseeable future as part of Premier’s performance services segment.

“This is a proven partnership,” said Keith J. Figlioli, senior vice president of healthcare informatics at Premier. “Premier and our member health systems have successfully partnered with CECity on the development and delivery of performance improvement solutions to accountable care organizations. So we already know our integrated solutions are effective.”

Expected financial contribution

Assuming realization of the expected long-term accelerated growth prospects of the business based on identified synergies with Premier and CECity’s quality, regulatory, education and research offerings, Premier expects the transaction to be accretive to adjusted fully distributed earnings per share by approximately 2-4 cents in fiscal 2016, and 8-10 cents in fiscal 2017.  Note: the expected fiscal 2016 and 2017 contributions from CECity are based on preliminary unaudited financial data and are subject to change based on an audit and disclosure of CECity’s financial results within 75 days after the close of the transaction.

Transaction terms and structure

Under terms of the agreement, Premier will purchase 100 percent of CECity’s outstanding stock for $400 million. This amount will be funded by $250 million of cash on hand and $150 million from borrowings under the company’s untapped $750 million revolving credit facility. The transaction is expected to close in Premier’s fiscal first quarter ending Sept. 30, 2015, subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and other customary closing conditions. Further information regarding all terms and conditions contained in the definitive stock purchase agreement will be included in Premier’s Current Report on Form 8-K, which will be filed with the SEC in connection with the transaction. 

About Premier, Inc.

Premier, Inc. (NASDAQ: PINC) is a leading healthcare improvement company, uniting an alliance of approximately 3,400 U.S. hospitals and 110,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier’s news and investor sites on www.premierinc.com; as well asTwitter, Facebook, LinkedIn, YouTube, Instagram, Foursquare and Premier’s blog for more information about the company.

About CECity®

Headquartered in Pittsburgh, Pa., CECity (www.cecity.com) is a leading provider of cloud-based healthcare solutions, specializing in performance improvement, pay-for-value reporting and continuous professional education. CECity combines its unique registry and Big Data analytics platform with education and improvement interventions from world-class partners to help stakeholders answer the most important question, “How Do We Improve?” Since 1997, leading healthcare organizations have trusted CECity to power and scale their high-stakes performance management solutions. CECity is a leading CMS qualified PQRS registry and powers approximately 20 percent of the nation’s Qualified Clinical Data Registries (QCDRs), which are aligned with PQRS, meaningful use and emerging payment models. CECity is the exclusive performance assessment organization for the Bridges to Excellence program.  CECity is also a partner in the joint venture, Pharmacy Quality Solutions, Inc. with the Pharmacy Quality Alliance and Ostonics Quality Systems, LLC with the National Osteoporosis Foundation. CECity’s clients include brand-name organizations from across the healthcare paradigm, including medical certifying boards, professional societies, EHRs, pharmacy chains, health systems, physician practices and health plans.

I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

BoardVitals Raises $1.1M to Build the Wikipedia of Medicine

Continues to grow market share across siloed medical education and accreditation landscape

NEW YORK, NY – (August 3, 2015) — BoardVitals, a rapidly growing healthcare startup based in New York City, announced today that it has raised $1.1 million in Series A funding from Rock Creek Capital, a Salt Lake City based growth equity fund. This follows initial seed funding from several investors, including Blueprint Health, Rothenberg Ventures, and Charles Boorady, the number one healthcare investor, according to Forbes.

BoardVitals has rapidly gained market share by redefining a siloed industry, medical assessments and certifications, and the company has been on a growth tear since it was founded in 2013. BoardVitals has trained over 30,000 doctors and the product has been purchased by over 150 institutions in the past year alone. The company was also named the ‘Most Promising Startup in New York’ as the winner of the 2014 Gust Catapult startup contest.

“BoardVitals will revolutionize the training of health care professionals in a way that will improve the quality of their lives and the quality of care they provide,” says Rick Stratford, a partner of Rock Creek Capital. “The exceptional talent and leadership of Dan Lambert and Dr. Andrea Paul has propelled BoardVitals into a market-leader in healthcare education in less than two years.”

Stratford will join the board of directors following the close of the Series A round. The board of directors also includes Greg Samios, former president of Kaplan Health and a long time adviser to the company.

“During my time working with Dan and Andrea, I have been extremely impressed by their ability to develop a unique assessment tool, which they have rapidly scaled across the healthcare marketplace,” said Samios.

The founding team is no stranger to fast growth companies. BoardVitals CEO Dan Lambert is a Harvard Business School graduate who co-founded Pushpins, a mobile couponing app that was acquired in 2013. Dr. Andrea Paul, chief medical officer, left her successful practice after 8 years of clinical experience to oversee content development. Dr. Paul was recently named one of 10 Disruptive Women in Life Sciences for her work on BoardVitals.

The company offers digital assessment tools that bring together medical content from major sources: publishers, research institutions, and more than 200 individual practitioners.

“It’s not only about new technology, it’s about building a new ecosystem for Medical Education,” says Lambert. “For the first time medical content is not just peer reviewed, but it’s now reviewed by hundreds of doctors within each specialty. Every piece of content on our platform is continually rated and we receive hundreds of feedback notices every week that ensure content is up to date.”

The $1.1M Series A round will be used to grow the team and increase the company’s market penetration. BoardVitals is also the first Manhattan-based company to be accepted into the recently created START-UP NY tax free zone.

About BoardVitals
BoardVitals is a healthcare education startup based in New York City that develops digital assessment tools and medical content to prepare physicians, nurses, and medical health professionals for specialty board exams and certifications. Bringing together content from major publishers, universities, and leading healthcare providers, BoardVitals provides the largest and most up to date training ecosystem in medicine. The company uses machine learning and crowd curation to identify and improve medical knowledge as information is published.  BoardVitals is backed by several investors including Blueprint Health, Rothenberg Ventures, and Rock Creek Capital. For more information, visit http://www.boardvitals.com.

About Rock Creek Capital

Rock Creek Capital, LLC is a growth equity investment firm based in Salt Lake City, Utah.  The partners of the firm, Rick Stratford, Tony Horsley and Jordan Clements, have collectively over thirty years experience in partnering with CEOs in building outstanding, high growth businesses in a range of industries, including business services, healthcare, specialty finance and manufacturing. High growth companies they have previously helped build include Vivint, Energy Solutions, Health Equity, Packsize, Signature Products Group, and Snap Finance, among others.

August 5, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

CHIME Applauds Bill (Flex-IT 2 Act) that Makes Necessary Improvements to Meaningful Use Program

Statement from CHIME CEO and President Russell P. Branzell, FCHIME, CHCIO and CHIME Board of Trustees Chair Charles E. Christian, CHCIO, LCHIME, FCHIME

ANN ARBOR, MI, July 30, 2015 – We commend Congresswoman Renee Ellmers for introducing the Further Flexibility in HIT Reporting and Advancing Interoperability Act of 2015 or “Flex-IT 2 Act” and appreciate her continued leadership on this critically important issue.

While CHIME remains committed to the success of Meaningful Use, and to making sure improved patient care is its lasting legacy, we believe significant changes are needed to address increased dissatisfaction with EHRs and growing provider dissatisfaction with the program. The introduction of the Flex-IT 2 Act serves to strengthen accountability and effectiveness of an e-enabled healthcare system and ensure long-term vitality of Meaningful Use.

There is no doubt that the EHR Incentive Payments program has been a vital and successful driver of health IT adoption nationwide, setting the foundation for better population health, improved care delivery and lower costs. However, the ongoing challenges with program implementation must be addressed. Our members believe in the intent and promise of Meaningful Use, but providers and hospitals alike have been hamstrung by its often overly prescriptive requirements. We view the Congresswoman’s legislation as an opportunity to reevaluate and reorient this vital program that will provide the digital infrastructure to support a 21st century healthcare system.

We look forward to working with Congresswoman Ellmers, our membership, and colleague provider organizations toward the passage of this important bill.

About CHIME:

The College of Healthcare Information Management Executives (CHIME) is an executive organization dedicated to serving chief information officers and other senior healthcare IT leaders. With more than 1,600 CIO members and over 150 healthcare IT vendors and professional services firms, CHIME provides a highly interactive, trusted environment enabling senior professional and industry leaders to collaborate; exchange best practices; address professional development needs; and advocate the effective use of information management to improve the health and healthcare in the communities they serve.

July 30, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Kareo Secures over $55 Million in Investment to Extend Market Leadership

Fully subscribed round led by Montreux Equity Partners, with participation from all current Kareo investors, to accelerate expansion of cloud-based product line for independent physicians

Irvine, CA – July 28, 2015Kareo, the leading provider of cloud-based solutions for independent medical practices, today announced it has closed $55.4 million in additional funding. This investment is led by Montreux Equity Partners with participation from Silver Lake Partners and all of Kareo’s existing investors. This capital will finance the continued development of Kareo’s product line—which enables physicians to manage all major aspects of their practice—as well as expand the company’s market access.

“With this new investment from Montreux, Silver Lake and our current investors, we’ll be able to accelerate the development of our comprehensive, cloud-based, medical office management platform for independent practices,” said Dan Rodrigues, founder and CEO of Kareo. “Concurrently, we will further expand our market reach, helping even greater numbers of physicians meet their care delivery and practice growth objectives.”

Montreux Equity Partners, a growth capital firm investing in high growth, commercial stage companies with category leading products, technologies and services has a history of investing in high-profile healthcare companies including MINDBODY Online (NASDAQ: MB), Glaukos (NYSE: GKOS) and MAKO Surgical (NASDAQ: MAKO, acquired by Stryker), among others. Along with the investment, Montreux Principal, Michael Matly, MD, will join the Kareo Board of Directors and will provide consultative guidance around the company’s market strategy. Dr. Matly brings valued experience in the health services and technology sectors and is actively involved in Montreux’s late stage investments. He previously represented Montreux on the board of MINDBODY Online (NASDAQ: MB) and currently serves on the board of Pure Life Renal. Before joining Montreux, Dr. Matly led Business Development and New Ventures at the Mayo Clinic Center for Innovation.

“We are very excited to invest in Kareo, a company dedicated to helping physicians deliver outstanding patient care without getting bogged down by administrative tasks and external mandates,” said Matly. “Independent practices are the foundation of the U.S. healthcare system, but they have been underserved by technology, often facing the choice of forgoing technology or deploying expensive and cumbersome enterprise solutions. Kareo is changing this.”

Montreux joins Kareo’s top-tier institutional investors, which include OpenView Venture Partners, Greenspring Associates, Stripes Group, Silicon Valley Bank and Western Technology Investments.

Kareo has been recognized as one of the nation’s fastest growing private companies, realizing a 368 percent increase in revenue over the past three years. In 2015, Kareo was named the leading vendor for integrated health records, practice management and physician billing solutions for the third consecutive year by Black Book and was identified by KLAS as a top-three practice management provider for practices with 1-10 physicians. The company serves over 30,000 healthcare professionals caring for 40 million patients and processes over $1 billion in medical claims monthly. In March, Kareo announced its acquisition of DoctorBase, an innovative developer of medical practice marketing and patient engagement solutions, and these solutions are now available to Kareo’s existing customers.

###

About Kareo
Kareo is the only cloud-based medical office solutions platform purpose-built for small practices. At Kareo, we believe that, with the right tools and support, small practices can do big things. We offer an integrated solution of products and services designed to help physicians get paid faster, find new patients, run their business smarter, and provide better care. Our practice management software, medical billing solution, practice marketing tools and free, award-winning fully certified EHR help more than 30,000 medical providers more efficiently manage the business and clinical sides of their practice. Kareo has received extensive industry recognition, including the Deloitte Technology Fast 500, Inc. 500/5000, Red Herring Top 100 Company, and Black Book #1 Integrated EHR, Practice Management and Billing Vendor. Headquartered in Irvine, California, the Kareo mission is to help providers spend their time focused on patients, not paperwork. For more information, visit www.kareo.com.

About Montreux Equity Partners
Montreux is dedicated to making growth capital investments in category-leading companies with products, technologies and services that are advancing health. Since 1993, Montreux has invested in more than 50 companies including MINDBODY (NASDAQ: MB), Glaukos (NYSE: GKOS), MAKO Surgical (acquired by Stryker), SkinMedica (acquired by Allergan), Renal CarePartners (acquired by Ambulatory Services of America), Great Lakes Health Plan (acquired by United Healthcare), and Orexigen (Nasdaq: OREX). Montreux is based in San Francisco, CA, and is currently investing out of its fifth fund. For more information, visit www.mepvc.com.

July 28, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Physicians Interactive Continues Growth with Acquisition of Quantia, Inc.

Quantia’s online physician community provides expert-led medical content and peer-to-peer collaboration to support clinical decision-making

READING, Mass. – (JULY 23, 2015) – Physicians Interactive (PI), the leading provider of insight-driven, digital engagement solutions for healthcare professionals and consumers, today announced that it has acquired Quantia, Inc. whose award-winning web and mobile community QuantiaMD, reaches more than one-third of U.S. physicians.

Physicians Interactive’s acquisition of Quantia, Inc., reflects PI’s continuing commitment to supplying  the best in expert medical content, tools and resources to healthcare professionals by integrating a digital physician community that enhances clinical decision-making, along with a talented team steeped in highly effective, online physician engagement.

“Healthcare professionals are inundated by data and, more than ever, need a solution that offers targeted medical information, education and peer-to-peer physician networks that keep them abreast of the latest in evidence-based medicine – and help ensure that they can deliver the best care to their patients,” said Donato Tramuto, Physicians Interactive Chairman and CEO. “By bringing Physicians Interactive and Quantia together, we continue to develop new ways to provide our customers, including health systems and life sciences companies, with the leading digital and mobile engagement platforms to help improve the quality and value of healthcare delivery.”

“On QuantiaMD, physicians average more than 20 minutes per session, learning from experts and peers within a highly dynamic web and mobile community,” said Nick Werthessen, Quantia Chief Operating Officer. “By combining our community with Physicians Interactive’s digital health platform, we can offer an unmatched level of healthcare professional reach and engagement to our customers, while empowering physicians to save time and enhance care via innovative digital and social technologies.”

About Quantia, Inc.

Quantia is on a mission to nurture the wisdom of the physician community – and tap into it to deliver better care. Every day, our membership of over 225,000 physicians (about one in three nationwide) visits the award-winning web and mobile community, QuantiaMD, to learn from top experts and collaborate on a wide range of topics. Our blend of expert-led content, gamification, and social framework creates an environment physicians want to explore, serving up high quality interactions that inspire change. Health systems and life sciences organizations use this platform to boost engagement among physicians, improving performance and delivering higher quality, more consistent care. Visit www.quantia-inc.com for more information.

About Physicians Interactive

Physicians Interactive has the largest global, digital health platform that engages and empowers consumers and healthcare professionals with instant access to content, solutions and data to improve health outcomes. The company provides payers, retailers and life sciences companies with sophisticated digital engagement solutions to reach, message, educate and change behaviors. Visitwww.physiciansinteractive.com for more information.

July 23, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Modernizing Medicine Announces Agreement to Acquire gMed

Boca Raton, Florida July 22, 2015 Modernizing Medicine, Inc. announced today that it has signed a definitive agreement to acquire Weston, Florida-based gMed, Inc.

The acquisition is expected to increase Modernizing Medicine’s gastroenterology market share with the addition of gMed’s electronic health record (EHR) system, endoscopy report writer, practice management solution, patient portal, data analytics tool and revenue cycle management.

“As a provider of EMR systems plus billing, revenue cycle management and inventory management solutions for medical specialties, the acquisition of gMed fits Modernizing Medicine’s specialty-specific focus and strengthens our product portfolio,” said Dan Cane, CEO and co-founder of Modernizing Medicine. “gMed’s gGastro product functionality complements our own EMA Gastroenterology™ EMR system and is compatible with our product development and growth strategy to be the industry’s foremost specialty-specific vendor.”

Modernizing Medicine’s acquisition of gMed is subject to certain customary conditions to closing. Pending fulfillment of such conditions, Modernizing Medicine currently anticipates closing the transaction in the third quarter of 2015.

“This acquisition aligns with our mission to offer the best gastroenterology-specific solutions and allows us to capitalize on our joint successes in the specialty EMR system market,” said Joe Rubinsztain, MD, CEO and founder of gMed. “We believe that blending our teams and areas of expertise will result in increasingly transformational products and services to better address the needs of more than 12,000 U.S. gastroenterologists and their staff.”

Rubinsztain will hold the title of President of gMed and become a part of the Modernizing Medicine senior management team following the closing. “I have watched the rapid growth of Modernizing Medicine and admire the reputation the company has gained in the market with its cloud, mobile and data-driven third generation EMR system, said Rubinsztain. “I expect this transaction to create greater benefits for end users and the most differentiating and comprehensive gastroenterology-specific products.”

About Modernizing Medicine

Modernizing Medicine® is transforming how healthcare information is created, consumed and utilized in order to increase efficiency and improve outcomes. Our flagship product, Electronic Medical Assistant® (EMA™), is a cloud-based, specialty-specific electronic medical records (EMR) system built by practicing physicians. Available as a native iPad application and from almost any web-enabled Mac or PC, EMA adapts to each provider’s unique style of practice. This ICD-10 ready EMR system is available for the dermatology, ophthalmology, orthopedics, otolaryngology, gastroenterology, urology and plastic surgery markets and used by over 6,000 providers in the United States and its territories. The Modernizing Medicine family of companies also provides specialty-specific billing and inventory management. Follow Modernizing Medicine on Twitter at www.modmed.com/twitter and on Facebook at www.modmed.com/facebook.

About gMed

gMed provides the gastroenterology industry with a fully integrated platform consisting of an Electronic Health Record, Endoscopy Report Writer, Practice Management solution, Patient Portal, a Data Analytics tool and Revenue Cycle Management. Fully scalable through the cloud or using an on-site server, gMed’s products are all Meaningful Use Certified and ICD-10 compliant.

July 22, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Dell Services Appoints Dr. Nick van Terheyden as New Chief Medical Officer

PLANO, Texas, July 20, 2015Dell Services announced today that Nick van Terheyden, M.D., former chief medical information officer of Nuance Communications, has been named Dell Healthcare & Life Sciences chief medical officer.

As chief medical officer, Dr. van Terheyden is responsible for providing strategic insight to help Dell advance its support of healthcare organizations, medical professionals and patients through information-enabled healthcare. He will report to Sid Nair, vice president and global general manager of Dell’s Healthcare & Life Sciences (HCLS) Services business.

“Dr. van Terheyden’s unique combination of medical experience, business strategy and creativity make him the perfect addition to Dell.” Sid Nair, vice president and global general manager, Healthcare & Life Sciences, Dell Services. “As Dell’s new chief medical officer, Dr. van Terheyden will play a key role in providing our customers access to expertise that is crucial in navigating clinical issues and applying innovative solutions in an increasingly complex healthcare industry.”

As a 25-year veteran of healthcare technology, Dr. van Terheyden is well-regarded for his contributions to the evolution of healthcare technology; as a thought leader and social media evangelist, Dr. van Terheyden will help Dell’s global healthcare customers develop a strategy and apply technology to achieve an IT environment that is interconnected, efficient and patient-focused. Prior to joining Dell, he served as chief medical information officer for Nuance, where he drove the company’s healthcare strategy to improve healthcare utilizing technology including speech recognition, medical intelligence and clinical language understanding to positively impact patient outcomes.

Dr. van Terheyden has impressive international experience in the Middle East, Australia, the UK, Malaysia and New Zealand. His diverse career experiences include collaborations with top healthcare organizations including Philips Healthcare, Mount Sinai Medical Center, KPMG, Healthcare International and Shell. Additionally, he aided in the development of one of the first electronic medical records, served as a business leader in one of the first speech recognition Internet companies. He is a graduate of the Royal Free Hospital School of Medicine, University of London and has several professional memberships including HIMSS, mHealth Executive Committee, AMIA, and AMDIS.

Dell continues to expand its commitment in the healthcare space through its end-to-end integrated solutions combining services, software and hardware—including patient engagement, predictive analytics, Healthcare Cloud & Interoperability, Clinical Applications Management as well as managed infrastructure, application and business process services. Dell has earned the ranking of number one in Healthcare Provider Services for six consecutive years by Gartner.

About Dell
Dell Inc. listens to customers and delivers innovative technology and services that give them the power to do more. As one of the leading providers of end-to-end IT solutions for healthcare worldwide, Dell helps healthcare organizations to simplify administration; coordinate and manage patient care; transition from episodic care to prevention and wellness management; and ultimately to deliver personalized medicine. Follow @DellHealth and @DellServices on Twitter.

Dell World
Join us Oct. 20-22 at Dell World 2015, Dell’s flagship event bringing together technology and business professionals to network, share ideas and help co-create a better future. Learn more at www.dellworld.com and follow #DellWorld on Twitter.

Supporting Resources:

July 20, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Accolade Secures $22.5 Million in Strategic Funding

PLYMOUTH MEETING, Pa. – July 16, 2015 – Accolade, the market-leading consumer health engagement platform for large employers and insurers, today announced that it has secured $22.5 million in strategic funding from a subsidiary of Independence Health Group, the parent company of Independence Blue Cross (Independence), and McKesson Ventures.

With this investment, Accolade will further strengthen its technology and analytics capabilities while capitalizing on a strong customer pipeline and growing market demand for healthcare solutions that are proven to save money, drive the right utilization and improve how consumers navigate the intricacies of the healthcare system to select high-quality care when it matters most.

“From day one, we’ve been focused on the consumer, and ways to help them overcome the incredible complexity of healthcare so that they get the right care,” says Accolade CEO Tom Spann. “It’s hugely gratifying to receive this latest round of funding from two innovation-driven companies that know healthcare and know Accolade and the kind of results we deliver. With this capital, we’ll invest in growing the business and enhancing our technology & analytics platform — while continuing to make a huge difference in the lives of the individuals and families we serve.”

Accolade currently works with some of the nation’s largest self-insured employers, health systems and health plans, including Independence. Its leading consumer engagement and influence solution helps consumers more effectively use their benefits and access the right care the first time. Accolade’s cloud-based platform integrates longitudinal consumer insights and proprietary algorithms to identify individualized care needs, match intervention types, optimize plans of action and personalize consumer outreach and messaging strategies across digital, mobile and personal channels.

“Accolade successfully marries technology with the personal touch of human interaction to effectively engage consumers, build trust and help members make better healthcare decisions,” said Independence President and CEO Daniel J. Hilferty. “Creating healthcare that’s focusing on what’s best for each individual is central to everything we do, and that personal touch is often one of the missing links in healthcare. We’re excited to invest in a company that is growing rapidly, delivering consistent results, and making the consumer’s healthcare experience a more meaningful and positive experience.”
Independence’s investment with Accolade is the most recent example of the company’s efforts to help establish Philadelphia as a global leader for healthcare innovation. Through its Center for Health Care Innovation, Independence has invested in helping nurture and grow more than 25 early-stage health-related companies engaged in the Dreamit Health business accelerator, and has partnered with national and regional healthcare leaders on joint research into critical issues such as medication adherence and reducing the incidence of diabetes.

According to Tom Rodgers, SVP and managing director of McKesson Ventures, Accolade perfectly aligns with the fund’s goal of investing in technology-enabled service companies that are enabling employers to more effectively influence consumer healthcare behavior and cost trends.

“We’re excited to support the continued growth and success of Accolade,” said Rodgers. “While there’s no shortage of innovative point solutions that address discrete healthcare issues, the reality is that they are highly underutilized, particularly by those who drive the most costs. In Accolade, we see a compelling concierge navigation platform that minimizes the hassle and confusion associated with our complex healthcare system, while generating the trust of employees and their families. This trust leads to influence, which allows Accolade’s customers to optimize the utilization of their other programs such as second opinion services, telehealth, cost transparency tools and centers of excellence programs which in turn optimizes their financial return.”

Independence and McKesson Ventures join previous investors Accretive LLC, Carrick Capital Partners, Oak Hill Capital Partners and Comcast Ventures.

About Accolade
Accolade is the country’s leading consumer healthcare engagement and influence platform for large self-insured employers and payer organizations. We help consumers navigate the complex world of healthcare and benefits, find the right providers and get the right care the first time. Our fully integrated solution is delivered through a powerful combination of Accolade Health Assistants® and advanced technology. By addressing some of the biggest problems facing healthcare – low engagement, lack of trust, and consumer knowledge gaps and errors – we’re able to consistently save our customers an average of 5-15 percent per year while delighting the individuals and family members we serve. Headquartered in Plymouth Meeting, Pa., Accolade has been recognized as one of the nation’s 25 most promising companies by Forbes magazine, the fastest-growing private healthcare company by Inc. 500 and a Top Workplace in Philadelphia for five consecutive years. For more information, visit www.accolade.com.

About Independence Blue Cross
Independence Blue Cross is the leading health insurance organization in southeastern Pennsylvania. With our affiliates, we serve nearly 10 million people in 24 states and the District of Columbia, including 2.5 million in the region. For nearly 80 years, we have been enhancing the health and wellness of the people and communities we serve by delivering innovative and competitively priced health care products and services; pioneering new ways to reward doctors, hospitals, and other health care professionals for coordinated, quality care; and supporting programs and events that promote wellness. To learn more, visit www.ibx.com. Connect with us on Facebook at ibx.com/facebook and on Twitter at @ibx. Independence Blue Cross and Independence Health Group are independent licensees of the Blue Cross and Blue Shield Association.

About McKesson Ventures
McKesson Ventures is the venture capital arm of McKesson Corporation specializing in early and growth stage companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. healthcare landscape by bringing greater efficiencies to patient care and improving the healthcare experience. McKesson Corporation, currently ranked 11th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We work with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that help deliver better care to patients in every setting. Visit mckessonventures.comto learn more.

July 16, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

medCPU Closes $8 Million Financing, Continues to Reinforce Leadership Position in Clinical Decision Support Market

NEW YORK, N.Y., July 14, 2015 – medCPU, Inc., a leader in enterprise clinical decision support solutions, announced today that it closed an $8 million financing round, consisting of $5 million series B-2 equity and $3 million in debt financing. The equity round was led by Merck Global Health Innovation Fund and New Richmond Ventures, and debt financing was provided by Silicon Valley Bank. This additional funding will enable medCPU to continue to assert its leadership position in the dynamic clinical decision support marketplace.

“We are driven by the confidence of our financial partners to further achieve our vision of changing the face of clinical decision support as it is known today,” said Sonia Ben-Yehuda, President and Co-Founder of medCPU, Inc. “In the past, the adoption of decision support has been stifled by outdated technologies that do not meet the needs of today’s clinicians. Unlike older, unreliable technologies that cause alert fatigue among clinicians, our solution delivers highly accurate and reliable decision support to clinicians at the point-of-care in real-time without disrupting their workflow.”

In a fast-paced environment where every detail is critical to a patient’s quality of care, real-time clinical decision support is a crucial component of a clinician’s workflow. The medCPU Advisor™, medCPU’s enterprise platform technology, acquires and processes both structured and unstructured data immediately as it is entered into a clinician’s Electronic Medical Record (EMR) system. The technology then assesses the data against best practice modules to provide the clinician with a holistic view of their patient and to ultimately provide highly accurate, real-time, reliable prompts at the point-of-care.

“We work with the most innovative companies, and those that have potential to transform the future of healthcare,” commented Michael Hanewich, Managing Director, Head of Life Science and Healthcare Venture Capital Relationships for Silicon Valley Bank. “The medCPU team has the vision and expertise to improve the accuracy and delivery of healthcare as it stands today.”

“Our technology is already being used by over 20,000 clinicians and a number of leading healthcare providers,” added Ms. Ben-Yehuda. ”This financing will help us to continue to grow our market share. We are excited about facilitating the move beyond antiquated, evidence-based reference tools to a new era of clinical decision support.”

medCPU’s solution is simple and seamless to deploy as it does not require integration into an EMR system or complex data connectivity to an interface engine. The medCPU Advisor™ enables healthcare providers to optimize investments already made in their EMRs. Running in the background of an EMR system unseen, the technology reads and captures data without disrupting a clinician’s workflow and only provides notifications when deviation from best practice care consideration occurs.

To meet the needs of different specialized health care organizations, medCPU delivers a wide range of customizable clinical and compliance decision support solutions, including modules for Obstetrics, Spine, Stroke, CHF, COPD, Value Based Purchasing, DRG’s, ICD-10, VTE Prophylaxis, Population Health, and in partnership with ILÚM Health Solutions™ (a subsidiary of Merck & Co., Inc. Kenilworth, NJ) is developing modules for Infectious Diseases such as Sepsis, Pneumonia and Urinary Tract Infection that also enable comprehensive Antimicrobial Stewardship.

About medCPU:
medCPU delivers accurate real-time enterprise decision support software and services through its proprietary Advisor technology. medCPU captures the complete clinical picture from clinicians’ free-text notes, dictations, discharge summaries and structured documentation entered into any Electronic Medical Record (EMR), and analyzes it against a growing library of best-practice content, generating real-time precise prompts for best care consideration. medCPU’s founding multi-disciplinary team has been pioneering new clinical decision support for nearly 20 years, delivering intelligent error reduction software systems to hospitals across the United States. medCPU’s applications include clinical and compliance support solutions. For more information, visit www.medCPU.com.

July 15, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.